Assessing infant iron deficiency through four to ten months of age.
A diet rich in iron should be considered for babies earlier than later, according to new research published in the December issue of Clinical Nutrition.
In a secondary analysis of results from a complimentary feeding trial, German researchers assessed the occurrence of iron deficiency and iron deficiency anemia in breast-fed infants (n=53) and infants fed an iron-fortified formula (n=23) during their first four months of life.
Iron intake was measured at four months of age (full breastfeeding period) and during a 7-to-10-month complementary feeding stage, at which point all infants were fed according to pediatric dietary guidelines.
At four months, three infants in the breast-fed group and one in the formula-fed group were considered iron deficient. Iron deficiency anemia was not developed by any infants at this time.
At seven months, iron intake was judged sufficient in all formula-fed infants; however, iron deficiency detected and iron deficiency anemia was detected in 10 and 2 breast-fed infants, respectively.
“This finding supports the recommendation that supplementation with bioavailable iron via complementary foods should be started early (4–6 months of age) in order to prevent iron deficiency during infancy,” concluded the researchers.
Read the full abstract of this study here.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.